Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000814133-18-000004
Filing Date
2018-02-05
Accepted
2018-02-05 13:02:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 sgmo218.txt SC 13G/A 2484
  Complete submission text file 0000814133-18-000004.txt   4140
Mailing Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108
Business Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 8015330777
WASATCH ADVISORS INC (Filed by) CIK: 0000814133 (see all company filings)

EIN.: 870319391 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Subject) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59049 | Film No.: 18573541
SIC: 2836 Biological Products, (No Diagnostic Substances)